|
Health insurers in N.Y.S. agree to change policies on covering hepC
(Preview)
Buffalo News, April 27th The seven insurers have reached an agreement with Attorney General Eric T. Schneiderman to allow improved access to meds needed to fight hepC. Prior to the agreement, a number of the insurers restricted access to the medications by requiring members to develop advanced...
|
keesotom
|
5
|
918
|
|
|
|
|
Egyptian Sovaldi generics
(Preview)
On stock already, contradictory availability. Links removed...sorry but these are not appropriate to post here. Jill (Forum Administrator) -- Edited by Cinnamon Girl on Sunday 22nd of February 2015 08:34:18 PM
|
kiten_ok
|
17
|
6246
|
|
|
|
|
Viekira Pak Updates
(Preview)
Viekira Pak produces high SVR for patients with HCV despite use of acid-inducing agents or Proton Pump Inhibitors. http://ipsite.org/3gzb
|
Tig
|
3
|
889
|
|
|
|
|
HCV 2016 Research and Updates
(Preview)
I thought this was a good article and recommend it for those in search of current treatment data. There is mention of two protease inhibitors, Telaprevir and Boceprevir (NS3), they should be disregarded. They are no longer being prescribed, thank goodness... I was one of the last to ride that train,...
|
Tig
|
6
|
1177
|
|
|
|
|
Jury Finds for Merck in Hepatitis Drug Fight With Gilead
(Preview)
Click here: http://ipsite.org/3gbb
|
wmlj1960
|
6
|
1388
|
|
|
|
|
FDA Expands Approval for HCV RNA test
(Preview)
The FDA has approved the HCV RNA test as a first test option to confirm active infection. Previously all patients had to be tested for HCV antibodies and then progress to the RNA if a positive antibody test was returned. This is a positive advance in diagnostics. http://ipsite.org/3g9p
|
Tig
|
2
|
847
|
|
|
|
|
Hepatitis C: California panel of experts say Solvadi is 'low value' treatment
(Preview)
As a part-time California resident, I've been following the ongoing debate there over the cost of the new treatments. The final report from the California Technology Assessment Forum isn't due until next month. I expect that report will establish guidelines that California insurers will use in a...
|
OldenSlow
|
4
|
1330
|
|
|
|
|
March and Mid-March 2016 editions of HCV Advocate newsletter
(Preview)
edition...http://hcvadvocate.org/news/NewsUpdates_pdf...
|
Cinnamon Girl
|
0
|
811
|
|
|
|
|
VA expands hepatitis C treatment to all patients with the virus
(Preview)
http://hepatitiscnewdrugs.blogspot.com/2016/03/va-expands-hepatitis-c-treatment-to-all.html
|
Matt Chris
|
0
|
813
|
|
|
|
|
European Commission approves extended use of Daklinza (daclatasvir) in 3 new patient categories, in Gen 1, 3 and 4
(Preview)
European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCVBristol-Myers Squibb has announced that the European Commission has approved Dakl...
|
Cinnamon Girl
|
1
|
1101
|
|
|
|
|
Harvoni and Depression
(Preview)
http://www.healthline.com/health/hepatitis-c/harvoni-depression#Overview1
|
Tig
|
0
|
1077
|
|
|
|
|
Top HCV Stories - 2015
(Preview)
Here's a collection of references pertaining to advances in care in 2015. Lots of good info from Healio. http://ipsite.org/3bf4
|
Tig
|
0
|
997
|
|
|
|
|
Statin use may reduce risk for cirrhosis in patients with HCV
(Preview)
http://www.healio.com/hepatology/hepatitis-c/news/online/%7B5c0f28b9-dd4f-4b31-8ceb-f92e3e944f89%7D/statin-use-may-reduce-risk-for-cirrhosis-in-patients-with-hcv-- Edited by Linuxter on M...
|
Linuxter
|
0
|
937
|
|
|
|
|
State Medicaid Restrictions for Hepatitis C Cures Are Creating One of America's Worst Health Disparities
(Preview)
Nice to see awareness becoming more mainstream. Ok State Medicaid(s), The Ball's in your court ... you're holdin' up the show.http://www.huffingtonpost.com/ryan-clary/state-medicaid-restrictions-for-hepatitis-c-cures-are-creating-one-of-americas-worst-health-disparities...
|
Linuxter
|
0
|
953
|
|
|
|
|
HCV Communication - Medicaid
(Preview)
I know some are having difficulty in getting approval for the new DAA HCV drugs via Medicaid. I think most of the problem lies at the State level not at the Fed level. Here's a "Communication" from Medicaid (the Feds) and I think there is little doubt that they intend for Medicaid patients to...
|
Linuxter
|
0
|
1175
|
|
|
|
|
!Letter From: CMS (Medicaid Fed) To: Each State re. New DAA HCV meds!
(Preview)
Not sure it will help anyone on Medicaid trying to get meds but there's some pretty strong language from CMS re. the restrictions states are putting on their Medicaid clients (i.e. Letter from the Feds to states saying you may be in violation of 1927 Social Security Act (Section ?) by placing these res...
|
Linuxter
|
2
|
986
|
|
|
|
|
Abbvie announce New Drug Application for once daily, fixed-dose formulation for Viekira Pak accepted by FDA
(Preview)
Dec. 2, 2015 - AbbVie today announced its New Drug Application has been accepted by the U.S. FDA for a once-daily, fixed-dose formulation of the components of VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets). VIEKIRA PAK is an all-oral, interferon-free treatm...
|
Cinnamon Girl
|
4
|
1227
|
|
|
|
|
Specialized Liver Transplant Procedures
(Preview)
http://hospitals.jefferson.edu/departments-and-servi...
|
Tig
|
2
|
922
|
|
|
|
|
NICE (UK) releases final guidance for access to Harvoni, Viekirax and Daklinza hepatitis C treatments
(Preview)
Following the release last month of provisional recommendations, the National Institute for Health and Care Excellence (NICE) has now published final guidance recommending Harvoni, Viekirax (with or without Exviera) and Daklinza for treatment of people with certain genotypes of hep C.The NI...
|
Cinnamon Girl
|
0
|
908
|
|
|
|
|
Gilead applies for FDA approval for sofosbuvir & velpatasvir combination treatment
(Preview)
On September 21, 2015 Gilead submitted their Phase 3 data of a once-daily combination of sofosbuvir (polymerase inhibitor) and velpatasvir (NS5A inhibitor) with and without ribavirin to treat genotype 1 through 6 patients to the FDA for marketing approval.Patients with decompensated cirrhos...
|
Cinnamon Girl
|
0
|
1006
|
|
|
|
|
UK Generic Breakthrough
(Preview)
From the blog of Greg Jeffreys, good news on the importation of generic medication for personal use. I hope this is a signal of equal opportunities for people everywhere. UK Generics Hep C Medication Importation
|
Tig
|
0
|
945
|
|
|
|
|
FDA Warning Issued over Viekira Pak/Technivie
(Preview)
The FDA just issued a warning regarding a potential risk to patients with cirrhosis (advanced fibrosis) that are taking the Abbvie drug protocols Viekira Pak and Technivie. Abbvie is updating their literature and notifying physicians of this possible adverse reaction. If you fall into this cate...
|
Tig
|
9
|
2237
|
|
|
|
|
NICE (UK) announce criteria for access to Daklinza, Harvoni, Viekirax and Exviera
(Preview)
Very good news for Hep C patients in the UK with Gen 1 and 4, and some with Gen 3!The National Institute of Clinical Excellence (NICE) have announced which of the new treatments would be made available by the NHS to people living with hepatitis C. This NICE decision is concerned with widening access be...
|
Cinnamon Girl
|
0
|
1118
|
|
|
|
|
Gilead Releases Phase 3 SVR Rates-Sovaldi/Velpatasvir (GS-5816)
(Preview)
Some very good news indeed! WOOT!! "FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 21, 2015-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced topline results from four international Phase 3 clinical studies (ASTRAL-1, ASTRAL-2, ASTRAL-3 and ASTRAL-4) evaluating a once-daily, f...
|
Tig
|
5
|
1550
|
|
|
|
|
LOOK - Healio HCV Updates
(Preview)
Here are some new updates that you should find helpful and informative. FDA Updates Labeling for Olysio C Tracker App Caffeine Decreases Fibrosis in HCV Infected Men
|
Tig
|
0
|
908
|
|
|
|
|
October 2015 - HCV Advocate Newletter
(Preview)
Lots of very interesting reading in this month`s issue, including articles on: Post treatment issues and how long it takes for the drugs to be eliminated from the body; An examination of RAVs and what causes them to occur: Up to date news on the latest drug developments. Link to full newsletter... htt...
|
Cinnamon Girl
|
1
|
811
|
|
|
|
|
FDA grants Priority Review for 3 New Drug Applications for Daklinza
(Preview)
Bristol Myers-Squibb announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review three supplemental New Drug Applications for Daklinza(daclatasvir), an NS5A replication complex inhibitor, for use with sofosbuvir with or without ribavirin.The applic...
|
Cinnamon Girl
|
0
|
840
|
|
|
|
|
The Biotech Sector is Exploding
(Preview)
Here's an interesting article on Biotech stocks, IPO's and Big Pharma's battle to be the best (and wealthiest) industry. "Gilead's Sovaldi and Harvoni were breakthrough treatments for the disease, but they were also the poster children of overpriced drugs. At list prices, a regimen o...
|
Tig
|
7
|
1569
|
|
|
|
|
New HCV ICD-10 Diagnosis Coding Update
(Preview)
An update effective Oct. 01, 2015 was made to the U.S. Medical diagnosis coding system. It's known as the ICD-10 or the International Classification of Diseases, 10th Revision. These are the codes your doctor must use when submitting your records to insurance for reimbursement. If these codes are...
|
Tig
|
0
|
914
|
|
|
|
|
An Australian hepatitis C sufferer has taken on Gilead by importing Sovaldi from India
(Preview)
http://www.abc.net.au/news/2015-08-20/hepatitis-c-sufferer-imports-life-saving-drugs-from-india/6712990
|
Matt Chris
|
5
|
1189
|
|
|
